NOVALIQ ANNOUNCES POSITIVE TOPLINE RESULTS FOR SECOND PHASE 3 ... - 22 December 2021 00:00

HEIDELBERG, Germany and CAMBRIDGE, MA Dec. 21, 2021 /PRNewswire-AsiaNet/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol(R) water-free technology, today announced key results of the second pivotal Phase 3 trial (ESSENCE-2) evaluating the investiga...

  CSTONE ANNOUNCED NEW DRUG APPROVAL OF CEJEMLY(R) (SUGEMALIMAB)... - 21 December 2021 20:56

SUZHOU, China, Dec. 21, 2021 /PRNewswire-AsiaNet/ -- CStone Pharmaceuticals (the "Company" or "CStone") is pleased to announce that the National Medical Products Administration ("NMPA") of China has approved the new drug application ("NDA") of anti-PD-L1 monoclonal antibody Cejemly(R) (sugemalimab) ...

  The New Era Biotechnology Brings The Cooperation Between China... - 21 December 2021 11:44

MINSK, Belarus, Dec. 21, 2021 /PRNewswire-AsiaNet/ -- New Era Biotechnology Co., Ltd is an enterprise from the Great Stone China Belarus Industrial Park (CBIP) in Minsk. It participated in the fourth edition of the China International Import Expo (CIIE) which opened in Shanghai on November 5, 2021. ...

  European Commission Grants Conditional Marketing Authorization... - 21 December 2021 06:43

GAITHERSBURG, Md., Dec. 21, 2021 /PRNewswire-AsiaNet/ -- -- Nuvaxovid(TM) COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine authorized for use in Europe -- Novavax and the European Commission previously announced an advance purchase agreem...

  World Health Organization Grants Second Emergency Use Listing ... - 21 December 2021 05:45

GAITHERSBURG, Md., Dec. 21, 2021 /PRNewswire-AsiaNet/ -- - Nuvaxovid(TM) COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]) listed for emergency use by the WHO - EUL for Nuvaxovid complements listing for Novavax vaccine manufactured and marketed by Serum Institute of India as Covovax(TM) ...

  2021 Sustainability Report of Sai Life Sciences highlights the... - 20 December 2021 23:06

HYDERABAD, India, Dec. 20, 2021 /PRNewswire-AsiaNet/-- - Report developed as per Global Reporting Initiative (GRI) standards - Extensively deals with the company's response to the Covid-19 pandemic Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Org...

  Japan's MHLW Approves Booster Shot for SPIKEVAX(R), Moderna's ... - 20 December 2021 12:00

MIAMI, Dec. 20, 2021 /PRNewswire-AsiaNet/ -- - The SPIKEVAX(R) brand name was developed in partnership with Brand Institute, the global leader in pharmaceutical and healthcare-related name development Brand Institute ( https://c212.net/c/link/?t=0&l=en&o=3394810-1&h=1068480144&u=https%3A%...

  Syntach AB Awarded an EU Grant of Euro 2.5 Million - 18 December 2021 06:27

LUND, Sweden, Dec. 17, 2021 /PRNewswire-AsiaNet/-- Syntach AB in Lund, Sweden has been awarded Euro 2.5 million as a grant and part of blended finance of up to Euro 17,5 million from the European Innovation Council (EIC) to support the development of its unique minimally invasive cardiac support s...

  Novavax and Serum Institute of India Announce World Health Org... - 18 December 2021 03:39

GAITHERSBURG, Md. and PUNE, India, Dec. 18, 2021 /PRNewswire-AsiaNet/ -- - First EUL granted by WHO for a protein-based COVID-19 vaccine - EUL vaccine manufactured and marketed by SII as COVOVAX(TM) - WHO EUL for Nuvaxovid(TM) currently under assessment; will be completed following European Medicines Ag...

  Thailand Launches ASEAN's First 5G Smart Hospital - 18 December 2021 03:19

BANGKOK, Dec. 17, 2021 /PRNewswire-AsiaNet/ -- - A Joint Launch by Siriraj, NBTC and Huawei Yesterday, Office of The National Broadcasting and Telecommunications Commission (NBTC), Siriraj Hospital, and Huawei Technologies (Thailand) Co., Ltd. jointly launched the "Siriraj World Class 5G S...